← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 7, 2023Last known activity
Feb 7, 2023
Acquired by Kala Pharmaceuticals on Nov 14, 2021
Timeline
2010s
- Jan 1, 2014
Combangio— Founded
2020s
- Nov 14, 2021
Kala Pharmaceuticals— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (1)
- NCT05727878Lead sponsorPhase 2Feb 7, 2023
Details
- Founded
- Menlo Park, CA, US Jan 1, 2014
- Last known activity
- Feb 7, 2023